SCHEMBL7435969

SCHEMBL7435969

CCOC(=O)N1CCC2(CC1)Oc1ccccc1O2

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.51
KMT2A Q03164 1/20 0.50
APP P05067 4/20 0.49
GAA P10253 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TSHR P16473 2/20 0.49
MAPT P10636 1/20 0.49
ALDH1A1 P00352 4/20 0.47
HPGD P15428 1/20 0.47
POLB P06746 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4221454 0.84 ALPG (0.51) L3MBTL1KMT2AAPPGAASMN1; SMN2
SCHEMBL5917702 0.84 KMT2A (0.50) L3MBTL1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL20616667 0.80 TRPM8 (0.59) KMT2ASMN1; SMN2ALDH1A1HPGDKDM4E
SCHEMBL30514942 0.79 KMT2A (0.46) L3MBTL1KMT2AAPPGAASMN1; SMN2
SCHEMBL25335749 0.79 KMT2A (0.46) L3MBTL1KMT2AAPPGAASMN1; SMN2
SCHEMBL7679291 0.79 APP (0.52) L3MBTL1KMT2AAPPGAASMN1; SMN2
SCHEMBL25337245 0.78 IDO1 (0.49) L3MBTL1KMT2AALDH1A1
SCHEMBL20616624 0.78 KMT2A (0.73) KMT2AGAASMN1; SMN2ALDH1A1HPGD
SCHEMBL5917726 0.77 KMT2A (0.44) L3MBTL1KMT2AAPPGAASMN1; SMN2
SCHEMBL7829437 0.76 APP (0.49) L3MBTL1KMT2AAPPGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207677-B1 ADMINISERING SIGMA RECEPTOR BINDING PIPERIDINE DERIVATIVE FOR TREATING ANXIETY, EPILEPSY, CONVULSION, MOVEMENT DISORDER, AMNESIA H. LUNDBECK A/S (DK) 2001-03-27 US disclosed
US-6031099-A Piperidine derivates having anxiolytic effect H. LUNDBECK A/S (DK) 2000-02-29 US disclosed
US-5807871-A PSYCHOLOGICAL DISORDERS, ALZHEIMER OR PARKINSON DISEASE H. LUNDBECK A/S (DK) 1998-09-15 US disclosed
EP-0593511-B1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT LUNDBECK & CO AS H (DK) 1998-09-02 EP disclosed
EP-0859004-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-08-19 EP disclosed
EP-0853085-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-07-15 EP disclosed
US-5665725-A Piperidine derivatives having anxiolytic effect Lundbeck, H. (DK) 1997-09-09 US disclosed
EP-0518805-A1 Piperidine derivatives H. LUNDBECK A/S (DK) 1992-12-16 EP disclosed